India reduces cancer drug prices by up to 96 percent starting Monday
By United One News · AI-generated summary of 3 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
The Indian government capped trade margins on 137 anti-cancer drugs, reducing prices by up to 96 percent across 1,225 formulations starting November 9.
- Consumers across India will save an estimated 3,502.31 crore rupees annually from the price reductions.
- About 1,000 brands show price reductions while 203 remain unchanged.
- Some individual medicine price reductions exceed 50 percent.
Covered by 3 outlets across the spectrum: 33% left, 67% center, 0% right.
How each side framed it
Prices of anti-cancer medicines to be reduced from November 9
Cancer drug prices to drop up to 96% from Nov 9
Timeline
First to report: Economic Times (); 3 articles from 3 outlets so far.
Who is covering this story
- Left-leaning (1): Greater Kashmir
- Center (2): Economic Times, The Hindu BusinessLine
Sources
- Cancer drug prices to drop up to 96% from Nov 9 — Economic Times (center) ·
- Revised prices on anti-cancer medicines effective from Monday, estimated annual savings of over ₹3500 crore — The Hindu BusinessLine (center) ·
- Prices of anti-cancer medicines to be reduced from November 9 — Greater Kashmir (left-leaning, AI-estimated) ·